TuHURA Biosciences (HURA) Non-Current Assets (2015 - 2026)

TuHURA Biosciences' (HURA) quarterly Non-Current Assets came in at $22.7 million in Q1 2026, up 7152.7% year-on-year from $313297.0 in Q1 2025, and little changed quarter-over-quarter from $22.7 million in Q4 2025.

TuHURA Biosciences (HURA) Non-Current Assets (2015 - 2026) Analysis & Trends

TuHURA Biosciences' Non-Current Assets history runs 12 years deep, the most recent figure standing at $22.7 million for Q1 2026.

  • On a quarterly basis, Non-Current Assets rose 7152.7% year-over-year to $22.7 million in Q1 2026; TTM through Mar 2026 was $89.7 million, a 4385.15% increase from a year earlier, with the FY2025 full-year figure at $22.7 million, up 6280.11% from the prior year.
  • Non-Current Assets steadied at $22.7 million in Q1 2026 per HURA's latest filing, from $22.7 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $22.7 million in Q4 2025 and bottomed at $202990.0 in Q4 2023.
  • The 5-year median for Non-Current Assets is $724000.0 (2023), against an average of $6.2 million.
  • Across the five-year window, Non-Current Assets slumped 86.27% in 2023 and surged 7152.7% in 2026, its largest moves.
  • Year by year, Non-Current Assets stood at $739000.0 in 2022, then sank by 72.53% to $202990.0 in 2023, then jumped by 75.52% to $356295.0 in 2024, then soared by 6280.11% to $22.7 million in 2025, then slipped by 0.04% to $22.7 million in 2026.
  • Per Business Quant, the three latest HURA Non-Current Assets figures stand at $22.7 million (Q1 2026), $22.7 million (Q4 2025), and $22.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 21.65 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 5.83 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 30.30 Mn
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1.95 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - 289.41 Mn
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 285.82 Mn
10 TuHURA Biosciences 132.62 Mn 132.62 Mn - 22.72 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 22.72 Mn
Dec 31, 2025 22.73 Mn
Sep 30, 2025 22.19 Mn
Jun 30, 2025 22.08 Mn
Mar 31, 2025 313,297.00
Dec 31, 2024 356,295.00
Sep 30, 2024 657,000.00
Jun 30, 2024 674,000.00
Mar 31, 2024 691,000.00
Dec 31, 2023 202,990.00
Sep 30, 2023 694,000.00
Jun 30, 2023 709,000.00
Mar 31, 2023 724,000.00
Dec 31, 2022 739,000.00
Sep 30, 2022 5.05 Mn
Jun 30, 2022 2.69 Mn
Mar 31, 2022 2.71 Mn
Dec 31, 2021 2.72 Mn
Sep 30, 2021 2.24 Mn
Jun 30, 2021 1.75 Mn